Anti-VEGF Therapy for Acute Thyroid Eye Disease

NCT04311606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Eye Disease

Interventions

DRUG: Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
DRUG: Sub-tenon injection of hyaluronidase (HA) followed by a sub-tenon injection of aflibercept
DRUG: Sub-tenon injection of hyaluronidase (HA) alone

Sponsor

Massachusetts Eye and Ear Infirmary

Collaborators

[object Object]